The trial, sponsored by University Hospital, Tours, investigates the impact of auditory rehabilitation on cognitive decline in Alzheimer's patients, a growing demographic with significant unmet needs. The market for hearing aids is expanding, particularly among the elderly population, which is increasingly affected by both hearing loss and cognitive disorders. If the trial demonstrates efficacy, it could position hearing aids as a critical component of Alzheimer's care, potentially leading to increased adoption and sales in this segment. Competitive analysis should focus on existing cognitive therapies and hearing aid manufacturers, assessing their market strategies and product offerings. Due diligence should include evaluating regulatory pathways and reimbursement scenarios in France and other European markets.